[go: up one dir, main page]

PL2633867T3 - Szczepionka do ochrony przeciw lawsonia intracellularis, mycoplasma hyopneumoniae i cirkowirusowi świń - Google Patents

Szczepionka do ochrony przeciw lawsonia intracellularis, mycoplasma hyopneumoniae i cirkowirusowi świń

Info

Publication number
PL2633867T3
PL2633867T3 PL13169835T PL13169835T PL2633867T3 PL 2633867 T3 PL2633867 T3 PL 2633867T3 PL 13169835 T PL13169835 T PL 13169835T PL 13169835 T PL13169835 T PL 13169835T PL 2633867 T3 PL2633867 T3 PL 2633867T3
Authority
PL
Poland
Prior art keywords
vaccine
protection against
mycoplasma hyopneumoniae
lawsonia intracellularis
against lawsonia
Prior art date
Application number
PL13169835T
Other languages
English (en)
Inventor
Antonius Arnoldus Christiaan Jacobs
Paul Vermeij
Ruud Philip Antoon Maria Segers
Carla Christina Schrier
Original Assignee
Intervet International B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39496087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2633867(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet International B.V. filed Critical Intervet International B.V.
Publication of PL2633867T3 publication Critical patent/PL2633867T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL13169835T 2008-04-18 2009-04-16 Szczepionka do ochrony przeciw lawsonia intracellularis, mycoplasma hyopneumoniae i cirkowirusowi świń PL2633867T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4618808P 2008-04-18 2008-04-18
EP08154765 2008-04-18
EP13169835.9A EP2633867B1 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus
EP09732113.7A EP2291195B2 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus

Publications (1)

Publication Number Publication Date
PL2633867T3 true PL2633867T3 (pl) 2018-07-31

Family

ID=39496087

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09732113T PL2291195T5 (pl) 2008-04-18 2009-04-16 Szczepionka do ochrony przeciw Lawsonia Intracellularis, Mycoplasma Hyopneumoniae i Cirkowirusowi świń
PL13169835T PL2633867T3 (pl) 2008-04-18 2009-04-16 Szczepionka do ochrony przeciw lawsonia intracellularis, mycoplasma hyopneumoniae i cirkowirusowi świń

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL09732113T PL2291195T5 (pl) 2008-04-18 2009-04-16 Szczepionka do ochrony przeciw Lawsonia Intracellularis, Mycoplasma Hyopneumoniae i Cirkowirusowi świń

Country Status (13)

Country Link
US (2) US20110033497A1 (pl)
EP (2) EP2291195B2 (pl)
JP (2) JP6026107B2 (pl)
CN (2) CN106729695A (pl)
BR (1) BRPI0909770B1 (pl)
CA (1) CA2718787C (pl)
DK (2) DK2633867T3 (pl)
ES (2) ES2534502T5 (pl)
HU (1) HUE038425T2 (pl)
PL (2) PL2291195T5 (pl)
RU (1) RU2496520C2 (pl)
TW (1) TWI449533B (pl)
WO (1) WO2009127684A1 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
EP2318041B1 (en) * 2008-07-22 2015-02-25 Intervet International BV Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
ES2559445T3 (es) 2010-05-11 2016-02-12 Intervet International B.V. Vacuna contra Mycoplasma hyopneumoniae apta para la administración en presencia de anticuerpos de origen materno
RU2565443C2 (ru) 2011-06-27 2015-10-20 Интервет Интернэшнл Б.В. Водная композиция, содержащая биологический антиген и полимер акриловой кислоты
WO2013104550A1 (de) * 2012-01-13 2013-07-18 Boehringer Ingelheim Vetmedica Gmbh Kit zur herstellung eines impfstoffs
US9474692B2 (en) * 2012-01-13 2016-10-25 Boehringer Ingelheim Vetmedica Gmbh Kit for the preparation of a vaccinating agent
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
CN104450559B (zh) * 2012-06-29 2017-09-22 普莱柯生物工程股份有限公司 新的猪肺炎支原体菌株及其疫苗组合物
CN103031258B (zh) * 2012-06-29 2014-12-17 普莱柯生物工程股份有限公司 新的猪肺炎支原体菌株及其疫苗组合物
EP2684959A1 (en) * 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
DK3076997T3 (en) * 2013-12-03 2018-12-10 Intervet Int Bv SVINEVACCINE v PRRS AND LAWSONIA INTRACELLULARIS
MX370584B (es) 2013-12-03 2019-12-17 Intervet Int Bv Vacuna contra lawsonia intracellularis y circovirus porcino 2.
PL3076996T3 (pl) * 2013-12-03 2020-05-18 Intervet International B.V. Szczepionka przeciwko cirkowirusowi świń typu 2
ES2800033T3 (es) 2015-02-04 2020-12-23 Intervet Int Bv Una vacuna para usar contra la infección asintomática por Lawsonia en un cerdo
JP2018504423A (ja) * 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
US11654191B2 (en) * 2016-03-23 2023-05-23 Intervet Inc. Vaccine for intradermal application against PCV2 and PRRS virus infection
EP3432919A1 (en) * 2016-03-23 2019-01-30 Intervet International B.V. A combination vaccine against pcv2 virus and mycoplasma hyopneumoniae infection
WO2018115435A1 (en) * 2016-12-23 2018-06-28 Intervet International B.V. Combination vaccine for swine
CN110446502B (zh) * 2017-04-13 2024-01-26 英特维特国际股份有限公司 用于联合非混合使用的含猪病原体的疫苗
CL2017002196A1 (es) * 2017-08-30 2017-11-17 Univ De Concepción Vacuna recombinante contra enteropatía proliferativa en animales.
CN120771270A (zh) * 2017-12-04 2025-10-14 英特维特国际股份有限公司 具有复制子颗粒和油佐剂的疫苗
CN118976103A (zh) 2017-12-18 2024-11-19 英特维特国际股份有限公司 猪甲型流感病毒疫苗
BR112022025735A2 (pt) 2020-06-19 2023-01-03 Intervet Int Bv Vacina de vírus da influenza a suína compreendendo um construto de ácido nucleico compreendendo a primeira, segunda e terceira sequências de ácido nucleico codificando antígenos de neuraminidase distintos do vírus
JP2023530135A (ja) 2020-06-19 2023-07-13 インターベット インターナショナル ベー． フェー． 特定のウイルス系統の抗原をエンコードする核酸構築物を含むブタインフルエンザａウイルスワクチン
CN115697398A (zh) 2020-06-19 2023-02-03 英特维特国际股份有限公司 包含两种不同rna复制子颗粒的甲型猪流感病毒疫苗
US20230265130A1 (en) 2020-06-19 2023-08-24 Intervet Inc. Swine influenza a virus vaccine comprising a nucleic acid construct having a specific order of genes

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE115862T1 (de) * 1989-02-04 1995-01-15 Akzo Nobel Nv Tocole als impfstoffadjuvans.
US5714375A (en) 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
CN1145697C (zh) * 1995-11-30 2004-04-14 维多利亚农业服务控股公司 治疗和诊断组合物
HUP0303655A2 (hu) * 2000-09-29 2004-03-01 Arizona Board Of Regents On Behalf Of The University Of Arizona Proliferatív ileitis elleni hatékonyabb vakcinák, előállításuk és alkalmazásuk
DE60120621T2 (de) * 2000-12-20 2006-12-14 Intervet International B. V. Lawsonia intracellularis Impfstoff
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
TW200510524A (en) * 2003-07-25 2005-03-16 Boehringer Ingelheim Vetmed Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
US7312065B2 (en) * 2003-07-25 2007-12-25 Boehringer Ingelheim Vetmedica, Inc. Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof
MXPA06008217A (es) 2004-01-22 2007-05-23 Intervet Int Bv Vacunas con subunidad de lawsonia intracellularis.
US20070212373A1 (en) * 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
BRPI0615862A2 (pt) * 2005-09-09 2011-05-31 Intervet Int Bv vacina contra pcv-2, e, método para a manufatura de uma vacina
DK1968630T5 (en) 2005-12-29 2018-08-13 Boehringer Ingelheim Vetmedica Inc MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS.
SG170792A1 (en) 2005-12-29 2011-05-30 Boehringer Ingelheim Vetmed Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
WO2007103042A2 (en) 2006-03-03 2007-09-13 Merial Limited Mycoplasma hyopneumoniae vaccine
PL2007419T3 (pl) 2006-04-10 2012-09-28 Intervet Int Bv Szczepionka przeciwko mykoplazmie i PRRSV
WO2007138036A1 (en) 2006-05-30 2007-12-06 Intervet International B.V. Vaccine against rickettsia-like organisms
CN101980720A (zh) 2008-01-23 2011-02-23 贝林格尔.英格海姆维特梅迪卡有限公司 Pcv2猪肺炎支原体致免疫组合物及其制备方法

Also Published As

Publication number Publication date
BRPI0909770A2 (pt) 2015-08-11
JP2015028038A (ja) 2015-02-12
BRPI0909770B1 (pt) 2021-09-28
TWI449533B (zh) 2014-08-21
CN102006884A (zh) 2011-04-06
DK2633867T3 (en) 2018-05-28
CN106729695A (zh) 2017-05-31
DK2291195T4 (da) 2020-02-10
EP2291195B2 (en) 2019-11-13
ES2534502T3 (es) 2015-04-23
CA2718787C (en) 2018-04-10
PL2291195T3 (pl) 2015-07-31
TW201000123A (en) 2010-01-01
DK2291195T3 (en) 2015-05-11
RU2010146950A (ru) 2012-05-27
ES2534502T5 (es) 2020-06-26
US20130183338A1 (en) 2013-07-18
CA2718787A1 (en) 2009-10-22
RU2496520C2 (ru) 2013-10-27
JP2011516601A (ja) 2011-05-26
HUE038425T2 (hu) 2018-10-29
EP2633867B1 (en) 2018-03-21
US20110033497A1 (en) 2011-02-10
EP2633867A1 (en) 2013-09-04
WO2009127684A1 (en) 2009-10-22
PL2291195T5 (pl) 2020-06-29
EP2291195B1 (en) 2015-02-25
JP6078504B2 (ja) 2017-02-08
ES2666844T3 (es) 2018-05-08
US9084768B2 (en) 2015-07-21
JP6026107B2 (ja) 2016-11-16
EP2291195A1 (en) 2011-03-09

Similar Documents

Publication Publication Date Title
PL2291195T3 (pl) Szczepionka do ochrony przeciw Lawsonia Intracellularis, Mycoplasma Hyopneumoniae i Cirkowirusowi świń
HUS2000047I1 (hu) Vakcina Lawsonia intracellularis elleni védelemre
HUS2500029I1 (hu) Alfa 2,3- és alfa 2,6-szalizációt tartalmazó rekombináns FSH
ZA201004026B (en) Mycoplasma hyopneumoniae avirulent-adjuvanted live vaccine
EP1991262A4 (en) MYCOPLASMA HYOPNEUMONIAE VACCINE
ZA200707799B (en) Immunogenic compositions comprising lawsonia intracellularis
IL206768A0 (en) Virtual keyboard and onscreen keyboard
AP2011005701A0 (en) Combination vaccine with acellular pertussis.
ZA200807228B (en) Anti-amyloid immunogenic compositions, methods and uses
GB201005292D0 (en) Virtual reality environment creating device, and controller device
SG10201401784WA (en) Vaccines Comprising Attenuated Mycoplasma Bovis Strains And Method For The Attenuation
ZA201001740B (en) Attenuated mycoplasma gallisepticum strains
IL193397A0 (en) Hpv antigens, vaccine compositions, and related methods
BR112012001756A2 (pt) "dispositivo de transmissão anti-queda para porta de manuseio com cortina flexível".,
ZA201005178B (en) Heat treated bacterins,and emulsion vaccines prepared from such heat treated bacterins
ZA201002515B (en) Live attenuated mycoplasma strains
BRPI0810865A2 (pt) antígenos de tripanossoma, composições vacinais, e métodos relacionados
TWI371241B (en) Fan, motor and bushing thereof
SI2066340T1 (sl) Toplotno obdelani bakterini in emulzijska cepiva, pripravljena iz takih toplotno obdelanih bakterinov
HUE051465T2 (hu) Vakcina Lawsonia intracellularis elleni védelemre
TH0901003809B (th) วัคซีนต้านกลุ่มอาการโรคของระบบสืบพันธุ์และทางเดินหายใจในสุกรชนิดก่อโรคได้สูง (hp prrs)
FI20086173A0 (fi) Menetelmä, tahtikone ja suojarelejärjestely tahtikoneen suojaamiseksi
GB0810759D0 (en) Virtual letter
HUE051918T2 (hu) Alfa 2,3- és alfa 2,6-szialilációt tartalmazó rekombináns FSH